Opinion
Video
Ronald D. Alvarez, MD, MBA, gives an analysis of the MIRASOL and DESTINY-PanTumor02 trials, including a comparison of study arms and discussion of HER2/neu targeting.
Proving the Concept: A Sampler of Early-Stage Science at AACR 2025
Five Years Later: Ongoing COVID-19 Challenges, Next Steps
Science at AACR Aims to Overcome Cancer Care Barriers
Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi
Contributor: For Complex Cases, Continuity in Acute Care Is Necessary
Higher Weight-Adjusted Waist Index Tied to Greater Mortality Risk in Patients With Osteoarthritis